参考文献/References:
[1] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2020年版)[J].中华结核和呼吸杂志,2020,43(12):1023-1048.
ASTHMA GROUP OF CHINESE THROACIC SOCIETY.Guidelines for bronchial asthma prevent and management(2020 edition) Asthma group of Chinese Throacic Society[J].Chin J Tuberc Respir Dis,2020,43(12):1023-1048.
[2] TEOH L,CHANG A B.Bird′s eye overview of asthma in children[J].Indian J Med Res,2021,154(1):8-11.
[3] STERN J,PIER J,LITONJUA A A.Asthma epidemiology and risk factors[J].Semin Immunopathol,2020,42(1):5-15.
[4] 全国儿科哮喘协作组,中国疾病预防控制中心环境与健康相关产品安全所.第三次中国城市儿童哮喘流行病学调查[J].中华儿科杂志,2013,51(10):729-735.
THE NATIONAL COOPERATIVE GROUP ON CHILDREN ASTHMA,INSTITUTE OF ENVIRONMENTAL HEALTH AND RELATED PRODUCT SAFETY,CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION.Third nationwide survey of childhood asthma in urban areas of China[J].Chin J Pediatr,2013,51(10):729-735.
[5] GBD 2015 CHRONIC RESPIRATORY DISEASE COLLABORATORS.Global,regional,and national deaths,prevalence,disability-adjusted life years,and years lived with disability for chronic obstructive pulmonary disease and asthma,1990-2015:a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet Respir Med,2017,5(9):691-706.
[6] HAMMAD H,LAMBRECHT B N.The basic immunology of asthma[J].Cell,2021,184(6):1469-1485.
[7] HABID N,PASHA M A,TANG D D.Current understanding of asthma pathogenesis and biomarkers[J].Cells,2022,11(17):2764.
[8] LUO W,HU J,XU W,et al.Distinct spatial and temporal roles for Th1,Th2,and Th17 cells in asthma[J].Front Immunol,2022,13:974066.
[9] LOPES FDTQS,TIBRIO IFLC,LEME A,et al.The importance of Th17/Treg imbalance in asthma and COPD development and progression[J].Front Immunol,2022,13:1025215.
[10] NTONTSI P,PHOTIADES A,ZERVAS E,et al.Genetics and epigenetics in asthma[J].Int J Mol Sci,2021,22(5):2412.
[11] ENAUD R,PREVEL R,CIARLO E,et al.The gut-lung axis in health and respiratory diseases:a place for inter-organ and inter-kingdom crosstalks[J].Front Cell Infect Microbiol,2020,10:9.
[12] 杨昕,黄淑敏,何静,等.肠道微生态在支气管哮喘发生发展中的作用研究进展[J].中华儿科杂志,2021,59(6):530-533.
YANG X,HUANG S M,HE J,et al.Research progress in the role of intestinal microbiome in the development of asthma[J].Chin J Pediatr,2021,59(6):530-533.
[13] MURDACA G,GEROSA A,PALADIN F,et al.Vitamin D and microbiota:is there a link with allergies?[J].Int J Mol Sci,2021,22(8):4288.
[14] 中华儿科杂志编辑委员会,中华医学会儿科学分会呼吸学组,中国医师协会儿科医师分会儿童呼吸专业委员会.儿童支气管哮喘规范化诊治建议(2020年版)[J].中华儿科杂志,2020,58(9):708-717.
THE EDITORIAL BOARD OF CHINESE JOURNAL OF PEDIA-TRICS,THE SUBSPECIALTY GROUP OF RESPIRATORY DISEASES of THE SOCIETYOF PEDIATRICS CHINESE MEDICAL ASSOCIATION,THE CHILDREN′S RESPIRATORY PROFESSIONAL COMMITTEE,THE SOCIETY OFPEDIATRICS OF CHINESE MEDICAL DOCTOR ASSOCIATION.Recommendations for diagnosis and management of bronchial asthma in children (2020) [J].Chin J Pediatr,2020,58(9):708-717.
[15] CASTRO-RODRIGUEZ J A,CIFUENTES L,MARTINEZ F D.Predicting asthma using clinical indexes[J].Front Pediatr,2019,7:320.
[16] 中华医学会变态反应分会儿童过敏和哮喘学组,中华医学会儿科学分会呼吸学组哮喘协作组,《中国实用儿科杂志》 编辑委员会.建立中国6岁以下儿童哮喘诊断标准的探讨[J].中国实用儿科杂志,2018,33(11):870-876.
THE SUBSPECIALTY GROUP OF PEDIATRICALLERGY AND ASTHMA,THE SOCIETY OF ALLERGIC REACTION,CHINESE MEDICAL ASSOCIATION;COOPERATIVE GROUP OF ASTHMA,THE SUBSPECIALTYGROUP OF RESPIRATORY,THE SOCIETY OF PEDIATRICS,CHINESE MEDICAL ASSOCIATION;THE EDITORIAL BOARD OF CHINESE JOURNAL OF PRACTICALPEDIATRICS.The establishment of diagnostic criteria for asthma in children aged<6 years[J].Chin J Pract Pediatr,2018,33(11):870-876.
[17] 中华医学会变态反应分会儿童过敏和哮喘学组.6岁以下儿童哮喘诊断标准验证的多中心研究[J].中国实用儿科杂志,2021,36(12):947-950.
PEDIATRIC ALLERGY AND ASTHMA GROUP OF CHINESE MEDICAL ASSOCIATION OF ALLERGY.Multi-center study on the verification of diagnosis criteria for asthma in children under 6 years of age[J].Chin J Pract Pediatr,2021,36(12):947-950.
[18] 谢艾岑,史文倩,梁蓉蓉,等.哮喘预测指数与哮喘预测评分对儿童哮喘的预测价值分析[J].新医学,2021,52(10):782-786.
XIE A C,SHI W Q,LIANG R R,et al.Analysis of predictive value of asthma predictive index and asthma prediction score in children with asthma[J].New Med,2021,52(10):782-786.
[19] GLOBAL INITIATIVE FOR ASTHMA.Global strategy for asthma management and prevention main report 2020[R/OL].(2020-03-20)[2020-05-15].https://ginasthma.org/reports/.
[20] 常春,孙永昌.2022版《全球哮喘管理和预防策略》更新解读[J].中国全科医学,2022,25(35):4355-4362.
CHANG C,SUN Y C.Global strategy for asthma management and prevention:interpretation of the updates in 2022[J].Chin Gen Pract,2022,25(35):4355-4362.
[21] 中华医学会儿科学分会呼吸学组肺功能协作组,《中华实用儿科临床杂志》编辑委员会.儿童肺功能系列指南(一):概述[J].中华实用儿科临床杂志,2016,31(9):653-658.
THE LUNG FUNCTION COLLABORATION GROUP OF RESPIRATORY GROUP,SOCIETY OF PEDIATRICS,CHINESE MEDICAL ASSOCIATION,EDITORIAL BOARD OF CHINESE JOURNAL OF APPLIED CLINICAL PEDIATRICS.Series guidelines on pulmonary function in children (1):overview[J].Chin J Appl Clin Pediatr,2016,31(9):653-658.
[22] BUSI L E,RESTUCCIA S,TOURRES R,et al.Assessing bronchodilator response in preschool children using spirometry[J].Thorax,2017,72(4):367-372.
[23] KING G G,BATES J,BERGER K,et al.Technical standards for respiratory oscillometry[J].Eur Respir J,2020,55(2):1900753.
[24] 罗汉球,卢珍通,曾子坤.脉冲震荡技术在儿童支气管哮喘诊治中的临床应用[J].现代医学与健康研究,2022,6(18):90-93.
LUO H Q,LU Z T,ZENG Z K.Clinical application of pulse concussion technique in the diagnosis and treatment of bronchial asthma in children[J].Mod Med Health Res,2022,6(18):90-93.
[25] 黄丽珍,郝创利,蒋吴君,等.脉冲震荡和常规肺功能检查在儿童哮喘中的相关性研究[J].临床儿科杂志,2020,38(12):896-899.
HUANG L Z,HAO C L,JIANG W J,et al.Correlation between impulse oscillometry and routine pulmonary function tests in asthma in children[J].J Clin Pediatr,2020,38(12):896-899.
[26] 李江华,李力,何勇.呼出气一氧化氮的研究进展[J/CD].中华肺部疾病杂志:电子版,2022,15(1):119-122.DOI:10.3877/cma.j.issn.1674-6902.2022.01.036.
LI J H,LI L,HE Y.Research progress of exhaled nitric oxide[J/CD].Chin J Lung Dis(Electr Ed),2022,15(1):119-122.DOI:10.3877/cma.j.issn.1674-6902.2022.01.036.
[27] LOEWENTHAL L,MENZIES-GOW A.FeNO in asthma[J].Semin Respir Crit Care Med,2022,43(5):635-645.
[28] HORVATH I,BARNES P J,LOUKIDES S,et al.A European Respiratory Society technical standard:exhaled biomarkers in lung disease[J].Eur Respir J,2017,49(4):1600965.
[29] EOM S Y,LEE J K,LEE Y J,et al.Combining spirometry and fractional exhaled nitric oxide improves diagnostic accuracy for childhood asthma[J].Clin Respir J,2020,14(1):21-28.
[30] 王梦娟,刘长山.呼出气一氧化氮检测在儿童哮喘诊治中的研究进展[J].国际儿科学杂志,2021,48(9):599-604.
WANG M J,LIU C S.Progress on detection of exhaled nitric oxide in diagnosis and treatment of asthma in children[J].Int J Pediatr,2021,48(9):599-604.
[31] 中华医学会变态反应分会呼吸过敏学组,中华医学会呼吸学分会哮喘学组.中国过敏性哮喘诊治指南(第一版,2019年)[J].中华内科杂志,2019,58(9):636-655.
THE RESPIRATORY ALLERGY GROUP OF CHINESE SOCIETY OF ALLERGY,THE ASTHMA GROUP OF CHINESE THORACIC SOCIETY,CHINESE MEDICAL ASSOCIATION.Chinese guidelines for the diagnosis and treatment of allergic asthma(2019,the first edition)[J].Chin J Intern Med,2019,58(9):636-655.
[32] TRINH H K T,LEE S H,CAO T B T,et al.Asthma pharmacotherapy:an update on leukotriene treatments[J].Expert Rev Respir Med,2019,13(12):1169-1178.
[33] LEVY M L,BACHARIER L B,BATEMAN E,et al.Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update[J].NPJ Prim Care Respir Med,2023,33(1):7.
[34] NWARU B I,EKSTROM M,HASVOLD P,et al.Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality:a nationwide cohort study of the global SABINA programme[J].Eur Respir J,2020,55(4):1901872.
[35] REDDEL H K,BACHRIER L B,BATEMAN E D,et al.Global Initiative for Asthma Strategy 2021:executive summary and rationale for key changes[J].Eur Respir J,2021,59(1):2102730.
[36] BEASLEY R,BECKERT L,FINGLETON J.Asthma and respiratory foundation NZ adolescent and adult asthma guidelines 2020:a quick reference guide[J].N Z Med J,2020,133(1517):73-99.
[37] ARAKAWA H,HAMASAKI Y,KOHNO Y,et al.Japanese guidelines for childhood asthma 2017[J].Allergol Int,2017,66(2):190-204.
[38] 高雅文,徐芳,姜鲁宁.支气管哮喘诊断及半胱氨酰白三烯受体拮抗剂治疗的研究进展[J].中华诊断学电子杂志,2021,9(1):67-70.DOI:10.3877/cma.j.issn.2095-655X.2021.01.015.
GAO Y W,XU F,JIANG L N.Research progress in diagnosis of bronchial asthma and treatment with cysteinyl leukotriene receptorantagonist[J].Chin J Diagn(Electr Ed),2021,9(1):67-70.DOI:10.3877/cma.j.issn.2095-655X.2021.01.015.
[39] ANDUJAR-ESPINOSA R,SALINERO-GONZALEZ L.Vitamin D supplementation:a treatment with possible benefits in asthma[J].Arch Bronconeumol,2021,57(9):567-568.
[40] AGACHE I,BELTRAN J,AKDIS C,et al.Efficacy and safety of treatment with biologicals (benralizumab,dupilumab,mepolizumab,omalizumab and reslizumab) for severe eosinophilic asthma.A systematic review for the EAACI Guidelines- recommendations on the use of biologicals in severe asthma[J].Allergy,2020,75(5):1023-1042.
[41] MARTIN J,TOWNSHEND J,BRODLIE M.Diagnosis and mana-gement of asthma in children[J].BMJ Paediatr Open,2022,6(1):e001277.